![Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada's AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada's AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in](https://bloximages.chicago2.vip.townnews.com/thedailytimes.com/content/tncms/assets/v3/editorial/d/7a/d7aa9f69-62fd-5b2e-af9a-2957a4641a2e/62838b320d4ed.image.jpg?resize=1396%2C837)
Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada's AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in
![Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva's Digihaler® Portfolio | Business Wire Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva's Digihaler® Portfolio | Business Wire](https://mms.businesswire.com/media/20201021005045/en/739014/5/teva_RGB_JPEG.jpg)
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva's Digihaler® Portfolio | Business Wire
![Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1l-image-113.jpg)
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire](https://mms.businesswire.com/media/20210408005437/en/868792/5/Teva_Canada_-_AJOVY_Autoinjector.jpg)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
![2021 Teva Respiratory, LLC. CIQ-41277 03/2021 Support for You and Your Patients Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients Teva Support Solutions® 1-844-838-2211 $0 Medication costs ... 2021 Teva Respiratory, LLC. CIQ-41277 03/2021 Support for You and Your Patients Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients Teva Support Solutions® 1-844-838-2211 $0 Medication costs ...](https://www.cinqairhcp.com/globalassets/cinqair-hcp-redesign/support-page-no-cost.png)